| 2024 | Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer
| BMC CANCER |
| 2024 | Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment | GYNECOLOGIC ONCOLOGY |
| 2024 | Restoring H&E stain in faded slides via phase-to-color virtual staining in near-infrared
| APL PHOTONICS |
| 2024 | Optimal Positioning of Load-Distributing Band CPR Device by Body Mass Index
| JOURNAL OF CLINICAL MEDICINE |
| 2024 | Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
| NATURE COMMUNICATIONS |
| 2024 | RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer
| FRONTIERS IN ONCOLOGY |
| 2024 | Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer
| SCIENTIFIC REPORTS |
| 2024 | Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor | AMERICAN JOURNAL OF SURGICAL PATHOLOGY |
| 2024 | Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 | INTERNATIONAL JOURNAL OF CANCER |
| 2023 | Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 | INTERNATIONAL JOURNAL OF CANCER |
| 2023 | Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution
| BIOMEDICINES |
| 2023 | Decidual lymphatic endothelial cell-derived granulocyte-macrophage colony-stimulating factor induces M1 macrophage polarization via the NF-κB pathway in severe pre-eclampsia | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY |
| 2023 | RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2023 | Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2023 | Cytological features of mesonephric-like adenocarcinoma of the uterine corpus | DIAGNOSTIC CYTOPATHOLOGY |
| 2023 | Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer
| GUT AND LIVER |
| 2023 | Region Segmentation of Whole-Slide Images for Analyzing Histological Differentiation of Prostate Adenocarcinoma Using Ensemble EfficientNetB2 U-Net with Transfer Learning Mechanism
| CANCERS |
| 2022 | RANDOMIZED COMPARISON BETWEEN SENTINEL LYMPH NODE MAPPING USING INDOCYANINE GREEN PLUS A FLUORESCENT CAMERA VERSUS LYMPH NODE DISSECTION IN CLINICAL STAGE I-II ENDOMETRIAL CANCER (KGOG2029/SELYE) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Mesonephric-like Carcinosarcoma of the Uterine Corpus: Clinicopathological, Molecular and Prognostic Characteristics in Comparison With Uterine Mesonephric-like Adenocarcinoma and Conventional Endometrial Carcinosarcoma
| CANCER GENOMICS & PROTEOMICS |
| 2022 | Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer
| FRONTIERS IN ONCOLOGY |
| 2022 | Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
| 2022 | p53 Immunohistochemistry and Mutation Types Mismatching in High-Grade Serous Ovarian Cancer
| DIAGNOSTICS |
| 2022 | Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma | JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES |
| 2022 | Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics
| DIAGNOSTICS |
| 2021 | Delayed postpartum regression of theca lutein cysts with maternal virilization: A case report
| Clinical and Experimental Reproductive Medicine |
| 2021 | Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component | MODERN PATHOLOGY |
| 2021 | Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY |
| 2021 | Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix | MODERN PATHOLOGY |
| 2020 | Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing
| CANCER RESEARCH AND TREATMENT |
| 2019 | Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
| SCIENTIFIC REPORTS |
| 2019 | Histopathologic characteristics of advanced-stage ROS1-rearranged non-small cell lung cancers | Pathology Research and Practice |
http://orcid.org/0000-0003-2658-5054
